Exact Mass: 415.2215

Exact Mass Matches: 415.2215

Found 78 metabolites which its exact mass value is equals to given mass value 415.2215, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(2S)-2-[[(2S)-2-Amino-3-(1H-imidazol-5-yl)propanoyl]-(2-benzamidoethyl)amino]-4-methylpentanoic acid

2-[2-Amino-N-(2-{[hydroxy(phenyl)methylidene]amino}ethyl)-3-(1H-imidazol-5-yl)propanamido]-4-methylpentanoate

C21H29N5O4 (415.2219)


   

3-benzhydryloxy-1-[2-(1,3-benzodioxol-5-yl)ethyl]piperidine

3-benzhydryloxy-1-[2-(1,3-benzodioxol-5-yl)ethyl]piperidine

C27H29NO3 (415.2147)


   

threo-2,3-dihydroxyechiumine

threo-2,3-dihydroxyechiumine

C20H33NO8 (415.2206)


   

lithosenine

lithosenine

C20H33NO8 (415.2206)


   

Molleurea A

Molleurea A

C26H29N3O2 (415.226)


   

Phe Ile His

Phe Ile His

C21H29N5O4 (415.2219)


   

His Phe Ile

His Phe Ile

C21H29N5O4 (415.2219)


   

His Ile Phe

His Ile Phe

C21H29N5O4 (415.2219)


   

Phe His Ile

Phe His Ile

C21H29N5O4 (415.2219)


   

Ile His Phe

Ile His Phe

C21H29N5O4 (415.2219)


   

Ile Phe His

Ile Phe His

C21H29N5O4 (415.2219)


   

zamifenacin

zamifenacin

C27H29NO3 (415.2147)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8319; ORIGINAL_PRECURSOR_SCAN_NO 8318 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8358; ORIGINAL_PRECURSOR_SCAN_NO 8357 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8363; ORIGINAL_PRECURSOR_SCAN_NO 8361 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8403; ORIGINAL_PRECURSOR_SCAN_NO 8402 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8404; ORIGINAL_PRECURSOR_SCAN_NO 8402 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8409; ORIGINAL_PRECURSOR_SCAN_NO 8407 Zamifenacin (UK-76654) is a potent gut-selective muscarinic M3 receptor antagonist. Zamifenacin significantly reduces colonic motility in irritable bowel syndrome[1].

   

Gly Pro Arg Ser

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C16H29N7O6 (415.2179)


   

Gly Pro Ser Arg

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C16H29N7O6 (415.2179)


   

Gly Arg Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C16H29N7O6 (415.2179)


   

Gly Arg Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C16H29N7O6 (415.2179)


   

Gly Ser Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C16H29N7O6 (415.2179)


   

Gly Ser Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C16H29N7O6 (415.2179)


   

Phe Leu His

Phe Leu His

C21H29N5O4 (415.2219)


   

His Leu Phe

His Leu Phe

C21H29N5O4 (415.2219)


   

Phe His Leu

Phe His Leu

C21H29N5O4 (415.2219)


   

Pro Gly Arg Ser

(2S)-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]-3-hydroxypropanoic acid

C16H29N7O6 (415.2179)


   

Pro Gly Ser Arg

(2S)-5-carbamimidamido-2-[(2S)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]pentanoic acid

C16H29N7O6 (415.2179)


   

Leu Phe His

Leu Phe His

C21H29N5O4 (415.2219)


   

Pro Arg Gly Ser

(2S)-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}-3-hydroxypropanoic acid

C16H29N7O6 (415.2179)


   

Pro Arg Ser Gly

2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-hydroxypropanamido]acetic acid

C16H29N7O6 (415.2179)


   

Pro Ser Gly Arg

(2S)-5-carbamimidamido-2-{2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}pentanoic acid

C16H29N7O6 (415.2179)


   

Pro Ser Arg Gly

2-[(2S)-5-carbamimidamido-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]acetic acid

C16H29N7O6 (415.2179)


   

His Phe Leu

His Phe Leu

C21H29N5O4 (415.2219)


   

Arg Gly Pro Ser

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetyl}pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C16H29N7O6 (415.2179)


   

Arg Gly Ser Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C16H29N7O6 (415.2179)


   

Arg Pro Gly Ser

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-hydroxypropanoic acid

C16H29N7O6 (415.2179)


   

Arg Pro Ser Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]acetic acid

C16H29N7O6 (415.2179)


   

Arg Ser Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H29N7O6 (415.2179)


   

Arg Ser Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H29N7O6 (415.2179)


   

Leu His Phe

Leu His Phe

C21H29N5O4 (415.2219)


   

Ser Gly Pro Arg

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-hydroxypropanamido]acetyl}pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C16H29N7O6 (415.2179)


   

Ser Gly Arg Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C16H29N7O6 (415.2179)


   

Ser Pro Gly Arg

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetamido)-5-carbamimidamidopentanoic acid

C16H29N7O6 (415.2179)


   

Ser Pro Arg Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]acetic acid

C16H29N7O6 (415.2179)


   

Ser Arg Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H29N7O6 (415.2179)


   

Ser Arg Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H29N7O6 (415.2179)


   

Crystal violet lactone

Crystal violet lactone

C26H29N3O2 (415.226)


   

3-phenylacrylic acid (2r,3s)-3-dibenzylamino-2-hydroxybutyl ester

3-phenylacrylic acid (2r,3s)-3-dibenzylamino-2-hydroxybutyl ester

C27H29NO3 (415.2147)


   

Celiprolol HCl

Celiprolol hydrochloride

C20H34ClN3O4 (415.2238)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

(S)-2-(3-BENZOYLPHENYL)-N-(4-HYDROXYPHENETHYL)-N-ISOPROPYLPROPANAMIDE

(S)-2-(3-BENZOYLPHENYL)-N-(4-HYDROXYPHENETHYL)-N-ISOPROPYLPROPANAMIDE

C27H29NO3 (415.2147)


   

(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-cycloheptylpyrrolidine-1-carboxamide

(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-cycloheptylpyrrolidine-1-carboxamide

C22H30ClN5O (415.2139)


   

ITD-1

ITD-1

C27H29NO3 (415.2147)


   

L-Phenylalanyl-L-histidyl-L-leucine

L-Phenylalanyl-L-histidyl-L-leucine

C21H29N5O4 (415.2219)


   

L-Leucyl-L-phenylalanyl-L-histidine

L-Leucyl-L-phenylalanyl-L-histidine

C21H29N5O4 (415.2219)


   

[1-acetyl-4-tert-butyl-3,6-bis(tert-butylsulfanyl)-3,6-dihydro-2H-pyridin-2-yl] acetate

[1-acetyl-4-tert-butyl-3,6-bis(tert-butylsulfanyl)-3,6-dihydro-2H-pyridin-2-yl] acetate

C21H37NO3S2 (415.2215)


   

17-O-deacetylvindolinium

17-O-deacetylvindolinium

C23H31N2O5+ (415.2233)


A vinca alkaloid cation that is the conjugate acid of 17-O-deacetylvindoline.

   

(2S)-2-[[(2S)-2-Amino-3-(1H-imidazol-5-yl)propanoyl]-(2-benzamidoethyl)amino]-4-methylpentanoic acid

(2S)-2-[[(2S)-2-Amino-3-(1H-imidazol-5-yl)propanoyl]-(2-benzamidoethyl)amino]-4-methylpentanoic acid

C21H29N5O4 (415.2219)


   

4-[(3aR,4R,9bR)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aR,4R,9bR)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C26H29N3O2 (415.226)


   

4-[(3aS,4R,9bS)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aS,4R,9bS)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C26H29N3O2 (415.226)


   

4-[(3aR,4S,9bR)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aR,4S,9bR)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C26H29N3O2 (415.226)


   

4-[(3aS,4S,9bS)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aS,4S,9bS)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C26H29N3O2 (415.226)


   

His-Phe-Ile

His-Phe-Ile

C21H29N5O4 (415.2219)


   

Leu-His-Phe

Leu-His-Phe

C21H29N5O4 (415.2219)


   

His-Leu-Phe

His-Leu-Phe

C21H29N5O4 (415.2219)


   

His-Ile-Phe

His-Ile-Phe

C21H29N5O4 (415.2219)


   

His-Phe-Leu

His-Phe-Leu

C21H29N5O4 (415.2219)


   

Ile-His-Phe

Ile-His-Phe

C21H29N5O4 (415.2219)


   

Ile-Phe-His

Ile-Phe-His

C21H29N5O4 (415.2219)


   

Phe-His-Ile

Phe-His-Ile

C21H29N5O4 (415.2219)


   

Phe-Ile-His

Phe-Ile-His

C21H29N5O4 (415.2219)


   

Phe-Leu-His

Phe-Leu-His

C21H29N5O4 (415.2219)


   

Leu-Phe-His

Leu-Phe-His

C21H29N5O4 (415.2219)


   

Phe-His-Leu

Phe-His-Leu

C21H29N5O4 (415.2219)


   

ST 18:0;O6;Gly

ST 18:0;O6;Gly

C20H33NO8 (415.2206)


   

4,5,24,24-tetramethyl-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,18,20-hexaen-22-one

4,5,24,24-tetramethyl-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,18,20-hexaen-22-one

C27H29NO3 (415.2147)


   

(22s)-4,5,10-trimethoxy-18-azahexacyclo[12.11.0.0²,⁷.0⁸,¹³.0¹⁶,²⁴.0¹⁸,²²]pentacosa-1(14),2(7),3,5,8(13),9,11,16(24)-octaene

(22s)-4,5,10-trimethoxy-18-azahexacyclo[12.11.0.0²,⁷.0⁸,¹³.0¹⁶,²⁴.0¹⁸,²²]pentacosa-1(14),2(7),3,5,8(13),9,11,16(24)-octaene

C27H29NO3 (415.2147)


   

{7-[(2,3-dihydroxy-2-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 2,3-dihydroxy-2-isopropylbutanoate

{7-[(2,3-dihydroxy-2-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 2,3-dihydroxy-2-isopropylbutanoate

C20H33NO8 (415.2206)


   

[(7r,7as)-7-{[(2s,3s)-2,3-dihydroxy-2-methylbutanoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

[(7r,7as)-7-{[(2s,3s)-2,3-dihydroxy-2-methylbutanoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

C20H33NO8 (415.2206)


   

(1s,4s,5s,16s,23r)-4,5,24,24-tetramethyl-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,18,20-hexaen-22-one

(1s,4s,5s,16s,23r)-4,5,24,24-tetramethyl-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,18,20-hexaen-22-one

C27H29NO3 (415.2147)


   

{7-[(3-hydroxy-3-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoate

{7-[(3-hydroxy-3-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoate

C20H33NO8 (415.2206)


   

[(7r,7ar)-7-[(3-hydroxy-3-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

[(7r,7ar)-7-[(3-hydroxy-3-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C20H33NO8 (415.2206)


   

n-(2-phenylethyl)-2-(2-{[(2-phenylethyl)-c-hydroxycarbonimidoyl]amino}ethyl)benzenecarboximidic acid

n-(2-phenylethyl)-2-(2-{[(2-phenylethyl)-c-hydroxycarbonimidoyl]amino}ethyl)benzenecarboximidic acid

C26H29N3O2 (415.226)